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Abstracts 215the ability of software BHC to remove density artefacts. Meaningful microCT
bone densitometry is possible provided that scans are made with suitable fil-
ter, appropriate BH correction is applied, x-ray absorption outside the cam-
era field of view (truncation) is minimal, and that as far as possible sample
(and calibration phantom) dimensions and mounting are standardised. Densi-
tometry is more accurate in the absence of surrounding media such as water
or tissue.
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Background: Natural herbal therapy offers an attractive alternative for
osteoporosis. The objective of this study is to evaluate the efficacy and
safety of natural Chinese herbs, Zuogui Pill (ZGP) and Yougui Pill (YGP),
for low bone mineral density (BMD).
Methods: 200 subjects were included double-blindly and randomly allocated
into two groups, treatment and control. All subjects were diagnosed with
low BMD and kidney deficiency in Traditional Chinese Medicine (TCM). Sub-
jects in treatment group were treated for 6 months with either ZGP or
YGP based on clinical characters of TCM, while control group received pla-
cebo for the same period of time. Primary outcome was lumbar BMD as
determined by using dual-energy X-ray absorptiometry. Secondary outcomes
included visual analogue scale (VAS), quality of life (ECOS-16), and serum
markers of bone metabolism. Adverse effects were documented for safety
assessment. Follow-ups were performed at regular intervals during a one-
year period.
Results: In ZGP group, lumbar BMD was increased by 4.1% immediately after
the treatment (P<0.05) and by 4.7% at the end of the additional 6-month
follow-up. Bone anabolic marker was also significantly improved after treat-
ment (P<0.05). In YGP group, the VAS and ECOS-16 scores were also signif-
icantly reduced after treatment (P<0.05). Furthermore, bone resorption
marker was significantly suppressed after treatment in YGP group
(P<0.05), and bone anabolic marker was significantly increased (P<0.05),
respectively. No severe adverse effects were observed.
Conclusion: ZGP and YGP are effective and safe therapeutic drugs for oste-
oporosis, which improve lumbar BMD, reduce pain intensity, alleviate bone
resorption, and stimulate bone formation.
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Menopause represents a period when many physiological changes develop
such as hypertension, a decrease in BMD, osteoarthritis and changes in bone
quality.Methods: In Department of Clinical Physiology and Pathology of Locomotor
Apparatus, Institute of Gerontology AMS Ukraine 115 women aged 46-78
(average age is 666,4) were subdivided into three groups: group I
comprised 42 patients with osteoarthritis roentgen phase II (Kellgren & Law-
rence, classification)), group II comprised 24 patients with hypertension sec-
ond degree, group III (13 women) with stage II osteoarthritis combined with
hypertension of the second degree. Bone mineral density (BMD) was deter-
mined by means of Dual-energy X-ray absorptiometer “Prodigy” (GE Medical
systems).
Results: BMD was decreased group III patients compared with women in I and
II group (0,97  0,05, 1,1  0,03 and 1,14  0,09 respectively p<0,05). This
indicates an violation bone quality due to influence of hypertension on bone
metabolism. The results point to necessity prescribe early treatment to
improve bone quality in group III women aged 60-80 years.
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Background: Diabetes affects over 170 million people globally. Peripheral
diabetic polyneuropathy is one of the more debilitating complications arising
from hyperglycemia, affecting 30-70 % of all diabetics and making it the
most prevalent painful neuropathy. Although diabetic neuropathy occurs
often and has characteristic clinical manifestations, it is typically poorly
diagnosed, especially in the early stages of the disease. Cellular and molec-
ular mechanisms of interaction of peripheral nervous system with a bone
metabolism till now poorly studied. Different screening methods have repro-
duced different results.
Aim: The aim of this study to assess the bone mineral density (BMD) of the
lower extremities in women in the postmenopausal period with diabetes
mellitus (DM) type 2 and its dependence from diabetic peripheral
polyneuropathy.
Method: This research have taken 51 women, average age 54,7  2,49 year
with DM type 2, of whom 29 were diagnosed with distal polyneuropathy of
the lower extremities. The control group consisted of 25 women, average
age 52,2  2,15 year with no risk factors for reduction in BMD. Clinical eval-
uation comprised clinical and neurologic status, questionnaire related to
osteoporosis (the Kanis, 2010), DN4, a visual analogue scale (VAS), scale
NISLL. BMD was determined by dual-energy x-ray absorptiometry (DXA)
(“Prodigy”, GE Medical systems).
Results: BMD (0.630.02) was significantly lower in patients with type 2 dia-
betes, complicated by distal polyneuropathy of the lower extremities,
compared with either patients without polyneuropathy (0.83 0,05
(pZ0.021)) or with healthy women (1.03  0.2 (pZ0.045)). This data con-
firms the impact of diabetic polyneuropathy on bone metabolism. Future
research will focus on these findings and comprise correlation with intensity
of pain syndromes to determine the value of a personalized treatment
approach.
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Background: Menopause is the special period in women’s life when many
physiological changes develop simultaneously, for example, hypertension,
decrease BMD, osteoarthritis, but, unknown how the quality of bone can
changes.
Methods: In Department of Clinical Physiology and Pathology of Locomotor
Apparatus, Institute of Gerontology AMS Ukraine 115 women aged 46-78
(average age is 666,4) were subdivided into three groups: group I
comprised 42 patients diagnosed with osteoarthritis (gonartritis) roentgen
phase II according to classification of Kellgren & Lawrence (1957), group II
comprised 24 patients with hypertension second degree, group III (13
women) with gonartritis of stage II in combination with hypertension of
216 Abstractsthe second degree. Bone mineral density (BMD) was determined by means of
Dual-energy X-ray absorptiometer “Prodigy” (GE Medical systems). Index
quality of bone (Trabecular Bone Score, TBS) was determined by programs
Med-Imaps iNsight , France.
Results: The results showed decrease TBS in group III aged 40-59 years
compared with women in only osteoarthritis (1,18  0,01 and 1,31  0,02
respectively p<0,05). This indicates an earlier violation bone quality in co-
morbid pathology, possibly due to influence of hypertension on bone meta-
bolism. In group III aged 60-80 TBS was decreased and did not depend on the
disease. It shows the influence of the duration of menopause on bone
quality.
Conclusion: The results point to necessity prescribe early treatment of
violation bone metabolism in women III group aged 40-59 years.
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Objective: The aim of our study was to evaluate the anthropometric charac-
teristics of the postmenopausal women depending on their appendicular
skeletal mass.
Materials and methods: We’ve examined 8882 women aged 20-89 years
(mean age e 56.70.14 yrs; mean height e 162.50.07 cm; mean weight
e 73.50.16 kg), taken anthropometric measures of 79 examined postmen-
opausal women aged 40-82 yrs (mean age e 63,531,08 yrs, mean height e
157,540,79 cm, mean weight e 74,751,68 kg). Appendicular skeletal
mass (ASM) was measured at all the four limbs with DXA. We’ve also calcu-
lated the appendicular skeletal mass index (ASMI) according to the for-
mula: ASM/height (kg/m2). During the quartile analysis, depending on
their ASMI parameters, the examined women were divided into the
following groups: Q1 e ASMI < 6,38 kg/m2 (nZ20), Q2 e ASMI Z 6,38-
6,83 kg/m2 (nZ20), Q3 e ASMI Z 6,84-7,36 kg/m2 (nZ20), Q4 e ASMI >
7,36 kg/m2 (nZ19). Anthropometric characteristics of the women were
evaluated according to the V.V.Bunak’s method (1941) modified by P.F.Sha-
parenko (1994). Lean and fat masses were measured with DXA using a Prod-
igy densitometer, GE. Statistical analysis was performed using the
«Statistica 6.0» software.
Results: Frequency of sarcopenia in the group of women aged 65 yrs and
older was 7 %. Quartile analysis of women taking into account their ASMI
revealed that the women of Q1 and Q2 groups had the following anthropo-
metric characteristics significantly reduced: weight (Q1 e 70,90 kg, Q2 e
70,25 kg, Q3 e 74,75 kg, Q4 e 85,53 kg; FZ5,24; rZ0,002), neck circumfer-
ence (Q1 e 350 mm, Q2 e 357 mm, Q3 e 376 mm, Q4 e 393 mm; FZ5,68;
rZ0,001), abdomen circumference (Q1 e 846 mm, Q2 e 936 mm, Q3 e
1008 mm, Q4 e 1106 mm; FZ11,52; r<0,0001), shoulder width (Q1 e 903
un., Q2 e 963 un., Q3 e 1029 un., Q4 e 1078 un.; FZ2,22; rZ0,09), narrow
tibia circumference (Q1 e 221 mm, Q2 e 227 mm, Q3 e 244 mm, Q4 e 248
mm; FZ6,44; rZ0,0006). We also observed a significantly lower thorax
circumference in the Q1 group (Q1 e 903 mm, Q2 e963 mm, Q3 e 1029
mm, Q4 e 1079 mm; FZ3,82; rZ0,01) in comparison with the women of
Q4 group (Q1 e 903 mm, Q2 e963 mm, Q3 e 1029 mm, Q4 e 1079 mm;
FZ3,82; rZ0,01).
Conclusion: In women with a lower ASMI (Q1 and Q2 groups) the following
anthropometric characteristics were significantly lower: weight, neck
circumference, abdomen circumference, shoulder width, narrow tibia
circumference. Thus, we can use anthropometric measures to determine
groups with an increased risk of sarcopenia and its complications.
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Introduction:Osteoporosis and sarcopenia are themost frequentmusculoskel-
etal disorders affecting older people. Fracture incidence aswell as the number
of fractures increase with population ageing. A low skeletal muscle mass is
associated with the poor structural bone parameters and impaired balance in
elderly people. The aim of this study is to evaluate the bone mineral density
(BMD), trabecular bone score (TBS) and body composition in women taking
into account the presence of vertebral fragility fractures (VFF).Materials and methods: We’ve examined 171 women aged 65-89 years
(mean age e 73.120.39 yrs; mean height e 1.580.004 m; mean weight
e 72.540.99 kg). The patients were divided into groups depending on pres-
ence of VFF: A e no VFF (nZ105; mean age e 72.700.54 yrs; mean height e
1.580.006 m; mean weight e 74.431.33 kg), B e present VFF (nZ66;
mean age e 73.790.55 yrs; mean height e 1.580.008 m; mean weight
e 69.531.37 kg). Total body, lumbar spine, femoral neck, forearm BMD,
lateral vertebral assessment, trabecular bone score (L1-L4), lean and masses
were measured by DXA densitometer (Prodigy, GE). Appendicular skeletal
mass (ASM) was measured at all the four limbs with DXA. We’ve also calcu-
lated the appendicular skeletal mass index (ASMI) according to the formula
ASM/height2 (kg/m2).
Results: We have found the following parameters to be significantly lower in
women with VFF compared to women having no VFF: BMD of total body (A e
0.8590.01 g/cm2, B e 0.7640.02 g/cm2; p<0.05), spine (A e 1.0380.02
g/cm2, B e 0.9270.03 g/cm2; p<0.05), femoral neck (A e 0.7870.01 g/
cm2, B e 0.7110.01 g/cm2; p<0.05), 33% forearm (A e 0.6900.01 g/
cm2, B e 0.6000.01 g/cm2; p<0.05), TBS (A e 1.1710.01, B e
1.1160.02; p<0.05), whole-body fat mass (A e 30736.87939.92 g, B e
25877.45966.90 g; p<0.05), whole-body lean mass (A e 41202.44498.18
g, B e 39440.77594.78 g; p<0.05), ASM (A e 16.470.22 kg, B e
15.810.22 kg; p<0.05) and ASMI (A e 6.590.07 kg/m2, B e 6.340.09
kg/m2; p<0.05). The frequency of sarcopenia was 2% in women with no
VFF and 14% in women with VFF.
Conclusion: Women with VFF have a significantly lower BMD, TBS, lean and
fat mass compared to women with no VFF.
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Introduction: Trabecular Bone Score (TBS, Med-Imaps, France) is an index of
bone microarchitectural texture extracted from antero-posterior spine DXA.
In this cross-sectional analysis from two facilities in Ukraine and Spain, we
have investigated the age-related changes of the lumbar vertebrae micro-
architecture assessed by TBS in a cohort of Caucasian men and compare
the results to TBS reference data for Caucasian women.
Methods: Subjects in the study were Ukrainian and Spanish men aged 40 and
older with a BMD Z-score at spine L1-L4 within  2SD. Individuals were
excluded if they had fractures, were on any osteoporosis treatment and/
or had any illness that would be expected to impact bone metabolism. All
data have been obtained from GE-Lunar DXA devices (Prodigy and iDxa, Mad-
ison, WI, USA). Cross-calibration between the two centers was performed for
TBS. TBS was evaluated at spine L1-L4 but also for all possible vertebrae
combinations.
Results: A database of 368 men aged 40 to 90 years was created. TBS and
BMD values at L1-L4 were poorly correlated with BMI (rZ0.16 and 0.22).
TBS was poorly correlated with weight (rZ-0.1) and height (0.03) whereas
higher correlations were obtained for BMD (rZ0.3 and 0.2). TBS values ob-
tained for all lumbar vertebral combinations decreased significantly with
age. There was a linear decrease of 13.5% (w-1.75 T-score) in TBS at L1-
L4 between 40 and 90 years of age in men while a decrease of 16.7%
(w-2.58 T-score) was observed in women (Dufour et al.,OI 2012). As opposed
to women, there is no change in the rate of TBS decrease after 65 years in
men.
Conclusion: This study established for the first time TBS age related curve in
European men in the lumbar spine. The decrease seen in lumbar TBS reflects
age-related micro-architecture texture changes at spine. Within the 40-65
age range, similar TBS decrease was observed in both Caucasian men and
women (pZ0.8). After 65, TBS decrease was significantly higher in women
than men (p<0.01). This study confirms the need to use gender specific
reference data.
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